Practice
Featured experience
Nordson $800 million acquisition of Atrion
We are advising Nordson on the acquisition
Gilead Sciences $4.3 billion acquisition of CymaBay Therapeutics
We are advising Gilead Sciences on the acquisition
Owens Corning $3.9 billion acquisition of Masonite International
We are advising Owens Corning on the acquisition
Equinix $2 billion at-the-market offering
We advised Equinix on the offering
Equinix $1.25 billion notes offering
We advised Equinix on the investment-grade offering
Novartis $6 billion notes offering
We advised Novartis on the investment-grade debt offering
ExxonMobil $112 million notes offering
We advised ExxonMobil on the investment-grade debt offering
Canadian National Railway $700 million notes offering
We advised Canadian National Railway on the offering
Venture Global LNG $2 billion revolving credit facility
We advised Venture Global LNG as borrower under the revolving credit facility
Strive $200 million preferred stock IPO
We advised Strive on its Nasdaq listing of preferred stock
Auna $400 million refinancing
We advised Auna on the transaction
MSCI $500 million notes offering
We advised MSCI on its investment-grade offering of senior notes
Banco Santander $2.8 billion notes offering
We advised Banco Santander on the offering
Galaxy $1.3 billion exchangeable senior notes offering
We advised Galaxy on the offering